ResearcherInstitute of Science TokyoActive in the last 2 years
Jun Yoshino
Matched on OpenAlex author ID A5140736560. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 1 paper · 2025: none · 2026: 3 papers
Papers 4
- Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20191-5↗
- ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20304-0↗
- ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20312-0↗
- Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era? First author DOI 10.21037/hbsn-24-603↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Asif Halimi · 4 shared papers, 2024–2026 · strength 1.01
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Nils O. Elander · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Hanna E. Seppänen · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Oskar Franklin · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Hakon Blomstrand · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Caj H. Haglund · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Ella Kesti · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Malin Sund · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Daniel Öhlund · 3 shared papers, 2026 · strength 0.77
- Paper Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20191-5↗
- Paper ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20304-0↗
- Paper ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. DOI 10.1245/s10434-026-20312-0↗
- Sofia Svensson Di Giorgio · 1 shared paper, 2024 · strength 0.24
- Alessandro Coppola · 1 shared paper, 2024 · strength 0.24
- Roberto Valente · 1 shared paper, 2024 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.